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AbstrACt
Objective To compare online and paper-based screening 
for depression and anxiety in adults with cystic fibrosis 
(CF).
Design and setting Cross-sectional study in CF clinics 
in Ireland and through the Cystic Fibrosis Ireland online 
community.
Participants 160 adult patients aged 18 or above were 
recruited. Of these, 147 were included in the analysis; 
83 online and 64 paper-based. The remaining 13 were 
excluded because of incomplete data.
Measures Depression and anxiety were measured using 
the Hospital Anxiety and Depression Scale (HADS). Data 
on pulmonary function (forced expiratory volume in 1 s %) 
and body mass index were self-reported based on clinical 
assessments. Sociodemographic data were collected.
results Compared with the paper-based participants, the 
online participants were more likely to be female (61.7% 
vs 48.4%), older (mean 32.2 vs 28.2 years) and were 
more likely to be married (32.5% vs 15.6%), living with 
their spouse or partner (42.5% vs 22.6%) and working 
either full time (33.7% vs 15.9%) or part time (30.1%vs 
17.5%). The prevalence rates of elevated anxiety and 
depression were not significantly different (P=0.71 and 
P=0.56). HADS anxiety and depression scores were not 
statistically different between online (P=0.83) and paper-
based (P=0.92) participants based on Mann-Whitney U 
test. A significant negative correlation was found between 
depression and pulmonary function (r=−0.39, P=0.01) 
and anxiety and pulmonary function (r=−0.36, P=0.02). 
Based on Cronbach’s alpha, there were no statistically 
significant differences between the online and paper-
based participants on the internal consistency of the HADS 
anxiety (P=0.073) and depression (P=0.378) scales.
Conclusions Our findings suggest that online and paper-
based screening for depression and anxiety in adult 
patients with CF yield comparable findings on prevalence 
rates and scores, associations with health and internal 
consistency of subscales. This study highlights that online 
screening offers an alternative method to paper-based 
screening. Further research with a larger sample and 
assessment of measurement equivalence between online 
and paper based screening is needed to confirm our 
results.
IntrODuCtIOn 
Cystic fibrosis (CF) is chronic, progressive 
and life-shortening, although increased 
survival rates into middle adulthood are now 
expected because of treatment and manage-
ment advances.1 The disease is characterised 
in part by increased susceptibility to recurrent 
chest infections due to excessive production 
of mucus in the small respiratory airways. In 
addition, obstruction of pancreatic enzyme 
secretion due to increased production of 
mucus in the gastrointestinal tract results in 
poor growth and weight loss.2 
To date, most research efforts have focused 
on understanding the pathophysiology of 
CF and the most promising treatment strat-
egies.3 However, in recent years, there has 
been a growing body of research on the 
psychological health of individuals with CF, 
strengths and limitations of this study
 ► This is the first study to explore online compared 
with paper-based screening of depression and 
anxiety in an adult population of patients with cystic 
fibrosis (CF).
 ► Given the recent publication on international 
guidelines for depression and anxiety screening in 
the CF population, our study is timely because it 
draws attention to online screening as an alternative 
method to paper-based screening.
 ► The small sample size and self-selection bias in this 
study are threats to its internal and external validity.
 ► A comparison of psychometric properties between 
the online and paper-based administration of the 
Hospital Anxiety and Depression Scale was limited 
to internal consistency; further research is needed 
to assess measurement equivalence, noting that 
the recent international guidelines support the use 
of the Patient Health Questionnaire-9 for depression 
and the General Anxiety Disorder 7-item scale for 
anxiety in the CF population.
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particularly on the prevalence of depression and anxiety, 
and their associations with physical health. The Interna-
tional Depression/Anxiety Study (TIDES) is a landmark 
collaboration across several European countries and 
the USA which screened for depression and anxiety in 
the CF adult and adolescent populations, and parent 
caregivers.4–9 In adults with CF, elevated depression and 
anxiety scores were associated with poorer lung function 
and quality of life.4 5 One of the main conclusions of 
TIDES was to recommend annual screening of patients 
with CF for symptoms of depression and anxiety, so that 
those affected received timely further assessment and 
treatment.4 This was endorsed by the European Cystic 
Fibrosis Society’s Standards of Care published in 2014.10 
In 2016, guidelines for screening and treating depression 
and anxiety from the International Committee on Mental 
Health in Cystic Fibrosis (ICMH-CF) were published 
recommending that annual screening be conducted 
by healthcare professionals, preferably mental health 
specialists.11
Studies on screening for depression and anxiety in 
patients with CF and their parent caregivers have collected 
data during clinic visits with high response rates.5 7 12–15 
However, high response rates seen in research may not 
be feasible within the context of routine clinic visits or 
annual review assessments. CF teams may face significant 
challenges in implementing screening for depression 
and anxiety. In a large-scale study on CF mental health 
delivery,16 limited staff time and limited personnel were 
ranked as the two highest barriers to implementing a 
mental health screening programme. Access to electronic 
tools for screening administration and scoring was ranked 
by 40% of respondents as among the top three areas 
that would be helpful in implementing mental health 
screening.16 Yet, to date, little consideration has been 
given to the possibility of online screening of patients 
with CF for depression and anxiety.
Computerised screening for depression has been 
available since the 1990s,17 with the potential for inter-
net-based screening of large populations.18 Online 
screening for depression and/or anxiety has been used 
in clinical populations such as patients with lung and 
breast cancer,19 and women with postpartum depres-
sion.20 Advantages of online screening include reduced 
costs,20 an ability to assess large populations,18 21 feasi-
bility and acceptability for patients to use,20 and a prac-
tical approach to screening for clinical teams.22 Reported 
disadvantages of online screening are the possibility that 
older adults may be less likely to participate,18 the need 
for computer literacy23 and that response or retention 
rates may be low.21
There has been no research to date comparing the 
results of online and paper-based assessment of mental 
health among patients with CF. Comparisons have been 
made in patients with tinnitus24 using the Hospital 
Anxiety and Depression Scale (HADS). Compared with 
the clinic paper-based sample, the online sample had 
higher prevalence rates of depression (17% vs 15%) and 
anxiety (25% vs 15%), and had significantly higher scores 
for both which the researchers speculated may have been 
due to anonymised self-recruitment offering an internet 
intervention on psychological support. Other researchers 
compared psychometric properties between online and 
paper versions of depression instruments administered 
to primary care and psychiatric care patients.22 The find-
ings indicated equivalence and no clinically relevant 
differences between method of administration with high 
correlations found between both scores. It is not possible 
to draw conclusions from existing research for the CF 
population because of the different clinical populations.
The aim of this study was to compare online versus clinic 
paper-based assessment of depression and anxiety in a CF 
adult population in Ireland in relation to sample char-
acteristics, prevalence data and associations with physical 
health (pulmonary function and body mass index; BMI). 
In addition, the study aimed to compare online and 
paper versions for internal consistency of the depression 
and anxiety measure, which for this study was the HADS.
MethODs
study design and setting
We conducted this exploratory study as part of a larger 
cross-sectional study in Ireland on the national prev-
alence of depression and anxiety in the CF population 
and associations with physical health and quality of life. 
The larger study included adolescents, their caregivers 
and adult patients. This paper reports on the adult data. 
We aimed to collect data from adults in all six adult CF 
centres in Ireland. At the outset, we intended to collect 
data during scheduled clinic visits similar to the studies 
involved in TIDES,4 and ethical approval was obtained 
for this. However, due to problems with recruitment data 
were also collected online.
Participants and recruitment
The study aimed to recruit adults with CF aged 18 years 
or over. The only exclusion criteria were adults who had 
received lung or heart–lung transplantation. Data avail-
able from the CF Registry of Ireland at the outset of the 
study indicated that the total adult population with CF 
aged 18 years and over was 595.25 In order to estimate 
the true proportion of depression and anxiety within a CI 
of ±3% for this population size, it was calculated that we 
needed to recruit 382 adults.
Our initial plan was to recruit adults during scheduled 
clinic visits at the CF centres. We sought access to the study 
sample through the CF teams by writing to the consul-
tant respirologists informing them about the study. We 
offered to meet the CF teams to discuss the study further, 
and a meeting was held in three of the six centres.
For three of the CF centres, access was generally 
unproblematic and was supported by the CF healthcare 
team. Access was not achieved in one centre because of 
no response to our efforts to contact the relevant respi-
ratory consultants. In two centres, staffing resource 
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constraints made data collection at clinics impossible. 
Research access to clinical sites can be challenging and is 
reliant on key gatekeepers in the services.26 27 Even in the 
remaining three clinics where we did have access, data 
collection was slow because of time constraints for adults 
in completing questionnaires or busy workloads of clinic 
staff making it difficult to administer questionnaires 
during clinic appointments. In view of the challenges 
faced in collecting data, we reapplied for ethical approval 
to recruit adults online through the Cystic Fibrosis Ireland 
(CFI) community network.
Data collection procedures
Data collection occurred between July 2014 and July 
2015. At clinics, patients were approached by a member 
of the CF multidisciplinary team and asked to participate 
in the study. Patients were informed that if they scored 
above the clinical cut-off for depression and/or anxiety 
symptoms, their CF consultant would be informed to 
ensure appropriate follow-up and psychological support. 
For this reason, data collection was not anonymous. After 
obtaining informed consent, patients were given the 
questionnaire pack which could be completed on site or 
at home and returned to the research team by stamped 
addressed envelope. Data collection was slow such that 
over a period of 12 months, paper-based data collection 
was completed for just 64 adults across three CF centres. 
Of these, 39 completed the questionnaire on site during 
a clinic visit and 25 completed the questionnaire at home. 
The questionnaire took approximately 15–20 minutes to 
complete. The response rates in the three centres were 
53%, 52% and 29%. The overall response rate for the 
clinic sample was 51%. Patients were not specifically 
asked for reasons for non-participation but some volun-
teered that they were ‘not interested’ or already involved 
in other research projects.
The online version of the questionnaire was developed 
and administered using the online survey development 
software, Survey Monkey. The link to the questionnaire, 
information sheet and consent form was emailed by the 
administrator of the CFI community network to 345 adults 
with CF with one follow-up reminder after 7 days. After a 
period of 2 weeks, 99 responses were collected which was a 
response rate of 29%; reasons for non-participation could 
not be gleaned. The invitation email clearly instructed 
that if the questionnaire was already completed during 
a clinic visit, there was no need to complete the online 
survey. We cross-checked all returned online question-
naires with paper-based questionnaires for duplication 
and removed three duplicates.
In total, 160 adult patients aged 18 or over were recruited 
from CF clinics or online. Of these, 147 were included in 
the analysis of whom 83 were the online sample and 64 
were the paper-based sample. The remaining 13 respon-
dents were excluded because of incomplete data. With 
595 adults entered in the CF Registry of Ireland,25 the 
sample size of 147 represented 27.6% of the adult CF 
population in Ireland.
Measures
Study packs contained: an information leaflet and consent 
form; a background information questionnaire and the 
HADS.28 The background information questionnaire 
gathered sociodemographic data such as age, gender, 
marital status, living arrangements and educational and 
employment information as well as a section on physical 
and mental health information. In this section, partici-
pants were asked to provide self-reported data, based on 
their most recent clinic visit, on their pulmonary function 
(forced expiratory volume in 1 s  %; FEV1%) and height 
(cm) and weight (kg) which were used to calculate BMI.
The HADS is a brief 14-item instrument used for 
screening depression (seven items) and anxiety symp-
toms (seven items). Each item requires the participant 
to select one statement from four options on a Likert 
scale. Scores range from a minimum of 0 to a maximum 
of 21 for both anxiety and depression. The HADS has 
well established clinical cut-off scores with a score higher 
than 7 indicating elevated symptoms of anxiety or 
depression and a score higher than 10 indicating anxiety 
or depression in the clinically significant range. The 
HADS has good psychometric properties as indicated 
by analysis of internal consistency, discriminant validity 
and factor structure.29 It was also the instrument used 
in TIDES to assess anxiety and depression symptoms in 
patients with CF,4 although since then the Patient Health 
Questionnaire-9 (PHQ-9) for depression and General 
Anxiety Disorder 7-item scale (GAD-7) for anxiety have 
been recommended through international consensus.11 
A referral process for follow-up psychological support 
was in place for participants with elevated depression 
and anxiety scores.
statistical analysis
Data were analysed using SPSS V.22.0 for Windows. To 
determine if there were statistically significant differ-
ences between the online and paper-based samples on 
demographic variables, independent samples t-tests and 
χ2 tests were run. In cases where 80% of expected cell 
count were not greater than five, or all expected cell 
counts were not greater than one, Fisher’s exact test was 
used. As the HADS data did not meet requirements of the 
normal distribution, the median and IQR are reported, 
and the Mann-Whitney U test was run to compare the 
online and paper-based samples. Prevalence of elevated 
and clinically significant anxiety and depression in 
online and paper-based samples were compared using 
χ2 tests. The mean and SD of physical health outcome 
variables, pulmonary function and BMI are reported, 
and the online and paper-based samples were compared 
using independent samples t-tests. To examine the rela-
tionship between HADS scores and physical outcome 
variables, Spearman’s correlation coefficients were 
calculated. Cronbach’s alpha was used to examine the 
internal consistency of the HADS anxiety and depres-
sion scales for both the online and paper-based samples, 
and Fisher-Bonett test was used to examine statistically 
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significant differences in Cronbach’s alpha between 
the two samples. Missing data were excluded from the 
analysis.
results
Demographic characteristics of online and clinic samples
A total of 147 adults with CF participated in the study. Of 
these, 56.5% (n=83) completed online and 43.5% (n=64) 
completed paper-based questionnaires. The demographic 
characteristics of the online and paper-based samples 
are presented in table 1. Significant differences were 
detected between the two groups in the demographic vari-
ables of age (P=0.008), marital status (P=0.044), general 
living arrangements (P=0.024) and employment status 
(P=0.005). There were no clear differences between the 
two groups for level of education.
Internal consistency of the hADs scale in online and paper-
based samples
The internal consistency of both online and paper-based 
HADS measure were similar. For the anxiety subscale, the 
Cronbach’s alpha level was 0.84 for the online sample 
and 0.89 for the paper-based sample. For the depression 
subscale, the alpha level was 0.87 for the online sample 
and 0.88 for the paper-based sample. There were no 
statistically significant differences between the online and 
paper-based samples on Cronbach’s alpha for the anxiety 
subscale (P=0.073) or depression subscale (P=0.378).
Prevalence of anxiety and depression
In the online sample, 25% (n=20) had HADS scores 
greater than 7 indicating elevated anxiety, and 11.3% 
(n=9) had anxiety scores in the clinically significant range 
with scores higher than 10. In the paper-based sample, 
28.1% (n=18) had elevated anxiety scores, and 14% (n=9) 
Table 1 Characteristics of adults with cystic fibrosis by method of data collection (n=147)
Online sample (n=83) Paper-based sample (n=64) P value
Age in years, mean (SD) 32.2 (7.3) 28.2 (10.6) 0.008
Gender, n (%) 0.131 
  Males 31 (38.3) 33 (51.6)
  Females 50 (61.7) 31 (48.4) 
Marital status, n (%) 0.044
  Single 37 (44.6) 42 (65.6)
  Married 27 (32.5) 10 (15.6)
  With partners 18 (21.7) 11 (17.2)
  Separated 1 (1.2) 1 (1.6)
General living arrangements, n (%) 0.024
  With parents 28 (35.0) 37 (59.7) 
  With partner/spouse 34 (42.5) 14 (22.6)
  With housemates 8 (10) 7 (11.3)
  Alone 10 (12.5) 4 (6.5)
Highest level of education, n (%) 0.318
  Masters/PhD 14 (17.2) 7 (11.3)
  Postgraduate cert/diploma 8 (9.9) 3 (4.8)
  Bachelor’s degree 18 (22.2) 19 (30.6)
  Technical cert/diploma 20 (24.7) 9 (14.5)
  Leaving certificate 14 (17.3) 16 (25.8)
  Junior certificate 7 (8.6) 7 (11.3)
  Primary school 0 (0.0) 1 (1.6) 
Employment status, n (%) 0.005
  Working full time 28 (33.7) 10 (15.9)
  Working part time 25 (30.1) 11 (17.5)
  Unable to work due to Illness 14 (16.9) 14 (22.2)
  Unemployed/seeking work 9 (10.8) 16 (25.4)
  Other (studying/retired/home maker) 7 (8.4) 12 (19)
Bold text represents significant P values.
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of the sample had anxiety scores in the clinically signifi-
cant range. For depression, 7.5% (n=6) of the online 
sample had elevated scores higher than 7 and 3.8% (n=3) 
of the sample scored within the clinically significant 
range higher than 10. In the paper-based sample, 10.9% 
(n=7) had elevated depression scores and 4.7% (n=3) had 
depression scores in the clinically significant range. There 
were no significant differences in prevalence between the 
online and paper-based samples who had elevated anxiety 
(P=0.71, 95% CI −0.12 to 0.19) or depression (P=0.56, 
95% CI −0.07 to 0.15) scores. Likewise, there was no 
significant difference in prevalence between those with 
clinically significant anxiety (P=0.61, 95% CI −0.0 to 0.16) 
or depression (P=0.78, 95% CI −0.07 to 0.11) scores.
hADs scores and physical health outcome variables
We compared the online and paper-based samples on 
their HADS scores and physical health outcome vari-
ables. As illustrated in table 2, there were no significant 
differences between the online and paper-based samples 
on their HADS anxiety (P=0.83) or depression scores 
(P=0.92). Similarly, there were no significant differences 
between the two groups on pulmonary function (P=0.39) 
or BMI values (P=0.60).
Associations between hADs scores and physical health 
variables
Table 3 illustrates the associations between HADS anxiety 
and depression scores with the physical health variables 
of pulmonary function and BMI for both the online and 
paper-based samples. The results of Spearman’s correla-
tion coefficient indicate that there was a significant 
negative correlation between HADS depression scores 
and pulmonary function for both the online (r=−0.39, 
P=0.002) and the paper-based (r=−0.36, P=0.016) samples. 
There were no significant associations between HADS 
anxiety scores and pulmonary function, or between 
HADS depression/anxiety scores and BMI for either the 
online or paper-based samples.
DIsCussIOn
In this cross-sectional study, we compared online and 
paper-based screening for depression and anxiety in 
adults with CF. Comparable results were found in both 
groups for prevalence rates and mean scores of depres-
sion and anxiety, with no statistical differences evident. 
Likewise, online and paper-based groups yielded similar 
results for associations between the mental health vari-
ables and physical health variables—pulmonary func-
tion (FEV1%) and BMI. In both groups, a significant 
negative association was found between depression and 
pulmonary function; the strength of this association was 
comparable. Neither group was found to have significant 
associations between anxiety and pulmonary function or 
between depression/anxiety and BMI.
In contrast to our finding, a previous study that used 
HADS in patients with tinnitus found significantly higher 
rates of depression in the online group.24 Self-recruit-
ment and the option to remain anonymous were offered 
as a possible explanation for this finding, indicating less 
inhibition in reporting mental health problems.24 In our 
study, although online participants were self-recruiting, 
they provided their names and contact details with the 
knowledge that HADS scores above clinical cut-off point 
would involve disclosing this information to their CF 
physicians to ensure appropriate follow-up care. Given 
the small samples in both groups in our study, there is a 
need for further research in larger samples to compare 
prevalence rates and scores of depression and anxiety 
using online versus paper-based assessment.
To the best of our knowledge, this is the first published 
study comparing online versus paper-based screening 
Table 2 Physical and mental health variables by method of data collection (n=147)
Online sample (n=83) Paper-based sample (n=64) P value
HADS anxiety (scale range 0–21) (Median, IQR, n) 5.00, 3.00–7.75, 80 5.00, 2.00–8.75, 64 0.83
HADS depression (scale range 0–21) (Median, IQR, n) 1.00, 1.00–4.00, 80 1.00, 1.00–4.00, 64 0.92
Pulmonary function (FEV1%) (mean, SD, n) 67.23, 25.07, 62 63.02, 23.90, 44 0.39
BMI (mean, SD, n) 22.01, 2.60, 67 21.74, 2.41, 38 0.60
BMI, body mass index; FEV1, forced expiratory volume in 1 s; HADS, Hospital Anxiety and Depression Scale.
Table 3 Association between HADS scores and health outcome variables by method of data collection (n=147)
Online sample (n=83) Paper-based sample (n=64)
HADS anxiety HADS depression HADS anxiety HADS depression 
Pulmonary function (r, P value*, n) −0.23, 0.09, 59 −0.39, 0.002, 59 −0.19, 0.23, 44 −0.36, 0.016, 44
BMI (r, P value, n) −0.08, 0.54, 64 0.12, 0.35, 64 −0.08, 0.65, 38 −0.16, 0.34, 38
Bold text represents significant P values.
BMI, body mass index; HADS, Hospital Anxiety and Depression Scale.
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of depression and anxiety in the adult CF population. 
Previous research comparing online versus paper-based 
assessment of mental health has been conducted in patients 
recruited from primary care or psychiatric care,22 patients 
with tinnitus24 and in psychology students.30 In these 
studies, regardless of the measurement used to assess 
anxiety and/or depression, the internal consistency for 
online and paper-based versions was similar. Our findings 
concur. In both the online and paper-based groups, the 
internal consistency of the HADS was comparably high 
and not significantly different. These findings suggest 
that online screening of mental health in adults with CF 
offers a reliable alternative to paper-based screening in 
clinical settings.
Our study demonstrated the potential of online mental 
health screening to yield higher participation rates within 
a shorter time frame compared with paper-based admin-
istration during clinics (or later at home). Over a period 
of 2 weeks, 99 HADS online questionnaires were returned 
whereas it took 12 months to collect 64 paper-based ques-
tionnaires. There is some evidence to suggest that paper-
based screening within clinical settings is a challenge. In 
a feasibility study31 on implementing the ICMH-CF guid-
ance11 on screening for depression and anxiety symp-
toms during CF clinics, concerns were expressed by staff 
that lengthy clinic visits and a requirement to complete 
‘another test’ were barriers to paper-based screening. 
Giving an option to take home the screening measure for 
completion was also seen as problematic because it risked 
non-return and the possibility of missing symptoms of 
depression or anxiety.31 A conclusion from that study was 
that there is a need to consider online screening outside 
the clinical setting to allow for faster administration 
and scoring.31 Given the time and resource constraints 
of conducting mental health screening during CF 
clinic visits,16 31 the participation rates within associated 
time frames identified in our study indicate that online 
screening may offer a practical alternative to paper-based 
screening and may contribute to increased participation 
rates. We acknowledge that our online response rate 
was low at 29%. A mitigating factor precluding us from 
extending the online survey beyond 2 weeks related to 
timelines for study completion set by the funding bodies. 
It is likely that the response rate would have been higher 
if more time was allowed, a finding evident in a feasibility 
study on web-based screening of physical symptoms in 
patients with CF which had a response rate of 80% over a 
9-month period that included repeated reminders.32
Our online and paper-based samples differed on a 
number of demographic variables, but they did not differ 
on lung function or BMI, and for both depression was 
associated with lower lung function. The online sample 
was older, more were married, living with a spouse/
partner and in full-time or part-time employment. It could 
be assumed from this finding that the online sample had 
busier life circumstances in which case online screening 
may be more convenient over paper-based screening. 
However, caution is needed with this assumption. Further 
research is required to determine the factors motivating 
the completion of online versus paper-based mental 
health screening among adult patients with CF. The 
acceptability of online screening among adults also needs 
consideration.
Mental health screening for depression and anxiety 
is now set to become integral to the health assessment 
of patients with CF based on international guidelines.11 
While our study demonstrates the potential of online 
mental health screening as a practical, efficient and 
reliable approach, there are issues to be considered 
regarding implementation into CF services. An infor-
mation technology infrastructure supporting the use of 
electronic health records is needed to ensure a seamless, 
paperless system. Electronic health records could be used 
to administer, score, track and provide results to health-
care professionals compliant with data protection legis-
lation. Peckham et al found that the implementation of 
electronic records incorporating a coding structure for 
CF care into CF centres of three hospitals led to greater 
efficiencies such that completion of annual assessments 
regarding physical health more than doubled from 43% 
to 92%.33 Furthermore, information exchange between 
multidisciplinary team members improved.33 A recent 
report on the e-Health status of European Union coun-
tries showed that almost half of the member states do 
not have national electronic health record systems with 
funding being a major barrier to their implementation.34 
The impact of implementing electronic records that 
include mental health assessment and care of adults with 
CF remains unknown to date.
A further consideration for clinical practice regarding 
online screening relates to patient feedback and follow-up 
care. In contrast to the immediate access that healthcare 
professionals have to patients during clinic visits, online 
screening is more removed and therefore requires a 
planned approach to providing feedback and follow-up 
care. There is evidence from an Australian study on the 
general population that tailored feedback following 
online screening may not promote the use of professional 
services to deal with mental health problems.35 In that 
study, mental health screening was not embedded within 
an existing health service that participants were using. 
While it could be expected that mental health screening 
of adults with CF that complies with the recent inter-
national guidelines11 will be embedded in CF services 
regardless of being online or paper-based, inadequate 
numbers of psychosocial professionals and staff trained 
in mental healthcare within CF teams is a concern.16 31
The findings of our study must be interpreted with 
some caution in light of limitations. The setting in 
which questionnaires were completed may have acted 
as a confounding variable as paper-based questionnaires 
were completed in clinics or in the participant’s home. 
Sample size was small in both online and paper-based 
groups, therefore undermining the internal and external 
validity of the findings. Self-selection bias exists which 
also threatens the internal and external validity of the 
 7Cronly J, et al. BMJ Open 2018;8:e019305. doi:10.1136/bmjopen-2017-019305
Open Access
findings. The comparable findings on prevalence rates of 
depression and anxiety between online and paper-based 
groups are not based on analyses that adjusted for base-
line differences in demographic data, for example, age, 
sex, education status and living arrangements. We did 
not adjust for baseline differences because of the small 
sample size. The cross-sectional design of the study did 
not allow for assessment of changes in depression and 
anxiety over time and what circumstances might influence 
these changes. Longitudinal data would help address this 
limitation.
A further limitation relates to the assessment of psycho-
metric properties in that Cronbach’s alpha only was used 
to test if method of administration differed for internal 
consistency. During the time of conducting our study, the 
reliability of the HADS as a clinical screening tool was 
critically questioned noting that although the HADS was 
used in TIDES, different measures were recommended 
from that international study.36 These measures were the 
PHQ-9 for depression and the GAD-7 for anxiety.4 36 Both 
these measures are recommended in the international 
guidelines for mental health screening of patients 
with CF,11 which are since being used in CF clinical 
settings.15 31 Because of the current shift away from using 
HADS as a screening tool for depression and anxiety in 
CF, and because of the small sample sizes in each group 
(online and paper-based), we did not test measurement 
invariance to determine if the online version of HADS 
is equivalent to the paper based version. Although scant, 
there is some evidence that depression scores between 
online and paper administration of the PHQ-9 are not 
significantly different.37 An online version of GAD-7 has 
been reported as reliable,38 but we found no evidence of 
comparisons with paper administration. Future research 
needs to conduct confirmatory factor analysis to assess 
the psychometric invariance between online and paper-
based administration of these screening tools in the 
CF population, including the settings in which they are 
administered.
A strength of our exploratory cross-sectional analysis is 
that it is the first to compare online versus paper-based 
assessment of depression and anxiety in adults with CF. 
In the TIDES international study, all data collection 
was paper-based.4 Therefore, our study draws attention 
to the potential of online screening for depression and 
anxiety in adult patients with CF. The similarities in find-
ings between both methods of administration is encour-
aging regarding prevalence rates of depression and 
anxiety, associations with pulmonary function and BMI. 
These findings demonstrate that online screening could 
be an alternative method to paper-based screening for 
those who prefer this option or miss clinic appointments, 
for example, due to family or work responsibilities; or 
wish to avoid spending extra time at clinics or annual 
review completing ‘another test’ as shown in previous 
research.31
COnClusIOn
In conclusion, some adult patients with CF experience 
symptoms of depression and anxiety. Both depression and 
anxiety can negatively impact on pulmonary function. 
The international recommendation for annual screening 
of depression and anxiety11 therefore applies to patients 
with CF living in Ireland. This study has highlighted that 
online screening offers an alternative method to paper-
based screening. The feasibility, acceptability, reliability 
and validity of online screening compared with paper-
based screening need further research.
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